Search Results - "Rasmusson, I."

Refine Results
  1. 1

    Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells by Rasmusson, I, Le Blanc, K, Sundberg, B, Ringdén, O

    Published in Scandinavian journal of immunology (01-04-2007)
    “…Mesenchymal stem cells (MSC) have immunomodulatory effects and inhibit T-cell responses to alloantigens and mitogens in vitro and in vivo. We wanted to examine…”
    Get full text
    Journal Article
  2. 2

    Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes by Le Blanc, K., Rasmusson, I., Götherström, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Tammik, C., Ringdén, O.

    Published in Scandinavian journal of immunology (01-09-2004)
    “…Mesenchymal stem cells (MSC) are immunomodulatory and inhibit lymphocyte proliferation. We studied surface expression of lymphocyte activation markers and…”
    Get full text
    Journal Article
  3. 3

    Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual by SUNDIN, M, ÖRVELL, C, RASMUSSON, I, SUNDBERG, B, RINGDEN, O, LE BLANC, K

    Published in Bone marrow transplantation (Basingstoke) (01-06-2006)
    “…Allogeneic stem cell transplantation is often complicated by reactivation of herpesviruses. Mesenchymal stem cells (MSC) are immunomodulatory and may be used…”
    Get full text
    Journal Article
  4. 4

    Immune modulation by mesenchymal stem cells by Rasmusson, Ida

    Published in Experimental cell research (15-07-2006)
    “…Mesenchymal stem cells (MSCs) have been shown to suppress activation of T cells both in vivo and in vitro. In vivo, this may be a way for the body to maintain…”
    Get full text
    Journal Article
  5. 5

    Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells by RASMUSSON, Ida, RINGDEN, Olle, SUNDBERG, Berit, LE BLANC, Katarina

    Published in Transplantation (27-10-2003)
    “…Mesenchymal stem cells (MSCs) can reduce the incidence of graft-versus-host disease because of their ability to inhibit T-lymphocyte proliferation. There are…”
    Get full text
    Journal Article
  6. 6

    Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells by Le Blanc, Katarina, Rasmusson, Ida, Sundberg, Berit, Götherström, Cecilia, Hassan, Moustapha, Uzunel, Mehmet, Ringdén, Olle

    Published in The Lancet (British edition) (01-05-2004)
    “…Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted…”
    Get full text
    Journal Article
  7. 7

    Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease by Ringdén, Olle, Uzunel, Mehmet, Rasmusson, Ida, Remberger, Mats, Sundberg, Berit, Lönnies, Helena, Marschall, Hanns-Ulrich, Dlugosz, Aldona, Szakos, Attila, Hassan, Zuzana, Omazic, Brigitta, Aschan, Johan, Barkholt, Lisbeth, Le Blanc, Katarina

    Published in Transplantation (27-05-2006)
    “…Mesenchymal stem cells (MSC) have immunomodulatory effects. The aim was to study the effect of MSC infusion on graft-versus-host disease (GVHD). We gave MSC to…”
    Get full text
    Journal Article
  8. 8

    Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes by Rasmusson, Ida, Uhlin, Michael, Le Blanc, Katarina, Levitsky, Victor

    Published in Journal of leukocyte biology (01-10-2007)
    “…Mesenchymal stem cells (MSCs), isolated from adult human bone marrow, have immunomodulatory properties. The functional outcomes of MSCs–CTL interactions remain…”
    Get full text
    Journal Article
  9. 9

    Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms by Rasmusson, Ida, Ringdén, Olle, Sundberg, Berit, Le Blanc, Katarina

    Published in Experimental cell research (15-04-2005)
    “…Human mesenchymal stem cells (MSCs) have immuno-modulatory properties. They inhibit T-cell proliferation to mitogens and alloantigens in vitro and prolong skin…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Complement compatibility of human mesenchymal stem cells during clinical infusion into whole blood for treatment of graft-versus-host disease by Moll, G, Rasmusson, I, Elgue, G, Sundberg, B, Ekdahl, K. Nilsson, Le Blanc, K, Nilsson, B

    Published in BONE MARROW TRANSPLANTATION (01-03-2009)
    “…Infusion of third-party mesenchymal stem cells (MSC) appears to be a promising therapy for graft-versus-host disease (GvHD). To date, little is known about the…”
    Get full text
    Journal Article Conference Proceeding
  12. 12
  13. 13
  14. 14
  15. 15

    Patient perspective on quality of geriatric care and rehabilitation - development and psychometric testing of a questionnaire by Wressle, Ewa, Eriksson, Lennart, Fahlander, Amie, Rasmusson, Ing-Marie, Tedemalm, Ulla, Tängmark, Karin

    Published in Scandinavian journal of caring sciences (01-06-2006)
    “…The aim was to develop and test a questionnaire for use in telephone interviews concerning patient evaluation of geriatric care and rehabilitation. Instrument…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Relatives' perspective on the quality of geriatric care and rehabilitation - development and testing of a questionnaire by Wressle, Ewa, Eriksson, Lennart, Fahlander, Amie, Håkansson, Helena, Jönsson, Anna-Lena, Martinsson, Britt-Marie, Rasmusson, Ing-Marie, Sjölander, Ingrid, Tängmark, Karin

    Published in Scandinavian journal of caring sciences (01-12-2008)
    “…We perceived a need for relatives’ evaluation of geriatric care and rehabilitation during the care period as well as the first few weeks after discharge. The…”
    Get full text
    Journal Article
  19. 19
  20. 20